The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment acce… [+5222 chars]
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk - CNBC
The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.
By:Annika Kim Constantino
Source:CNBC
Published:
Related News
Takaichi Warns Japan Is Ready to Act on Speculative Moves - Bloomberg.com
Japanese Prime Minister Sanae Takaichi sent a fresh warning to financial markets amid a weakening yen and surging bond yields, saying the government will be ready to take action.
Bloomberg•Takashi Mochizuki
AAPL vs. MSFT vs. TSLA: Wall Street’s Favorite Magnificent 7 Stock Ahead of Q4 Earnings Season - TipRanks
Four of the “Magnificent 7” stocks — Apple ($AAPL), Tesla ($TSLA), Microsoft ($MSFT), and Meta Platforms ($META) — are set to report earnings next week, between January 26 and January 30. Using TipRanks’
Tipranks.com•Shalu Saraf
Winter storm could knock out power for up to 200,000 Houston area customers, CenterPoint says - khou.com
CenterPoint Energy projects 100,000 to 200,000 outages across Houston area over the course of the storm.
KHOU.com•Anne James